BME-Industry Grand Rounds, April 8: New Treatments for Epilepsy and Acute Anxiety
![Robert K. Schultz and Ronald A. Siegel](/sites/cse.umn.edu/files/styles/webp_scaled/public/bme-industry-grand-rounds-4.8.24-speakers_0.jpg.webp?itok=mp2X-a4T)
Emergency in the Emergency Department
Robert Schultz, Ph.D., President and CEO, Sollievo Pharmaceuticals, Inc.
Intranasal Delivery of a Diazepam Prodrug for Rapid Reversal of Seizures
Ronald A. Siegel, Sc.D., Professor, Departments of Pharmaceutics and Biomedical Engineering, University of Minnesota